Report cover image

Europe Wound Biologics Market - Focused Insights 2023-2028

Publisher Arizton Advisory and Intelligence
Published Nov 09, 2023
Length 76 Pages
SKU # ARZ18299681

Description

Europe Wound Biologics Market - Focused Insights 2023-2028


REPORT OVERVIEW

This report offers market size & forecast data for the wound biologics market in Europe. The revenue generated from the sale of wound biologics products are included in the report. This report provides a comprehensive and current market scenario of the Europe wound biologics market, including Europe wound biologics market size, anticipated market forecast, relevant market segmentations, and industry trends.

The study considers a detailed scenario of the present wound biologics market and its market dynamics for 2023−2028 in Europe. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.

MARKET DEFINITION

The products derived from living organisms or cells for treating wounds are called wound biologics. These are intended to facilitate the re-establishment of innate repair mechanisms.

KEY HIGHLIGHTS
  • In Europe, the wound biologics market was valued at $420.00 million in 2022 and is expected to reach $710.02 million during the forecast period.
  • By End-user, the specialty wound clinics accounted for the highest share of 54.33% in 2022 and are projected to grow at the highest CAGR of 9.51% during the forecast period. This is mainly due to the outsourcing by hospitals for wound treatment.
  • By Product type, the biological skin substitutes segment accounted for the highest share of 59.44% in 2022 and is projected to grow at the highest CAGR of 8.81% during the forecast period. The increasing demand for biological skin substitutes is due to the rising number of diabetic wounds, increased preference for wound biologics, and the geriatric population.
  • By Wound type, the chronic wounds segment accounted for the highest share of 54.55% in 2022 and is projected to grow at the highest CAGR of 9.64% during the forecast period. This is due to many factors, such as increasing cases of diabetes, obesity, and advanced age, that contribute to the rise in the number of chronic wound cases.
  • The demand for wound biologics market is rising due to multiple factors, including an increasing geriatric population, growing consumer awareness regarding usage, high prevalence of chronic and acute wounds, and increasing adoption of wound biologics.
  • Other factors such as technological & material advancements, introduction of new products, well-developed healthcare infrastructure, extensive research & development activities, presence of leading key vendors, and government support also contribute to the growth of the overall wound biologics market.
VENDORS LIST
  • Avita Medical
  • Organogenesis
  • Smith+Nephew
  • Vericel Corporation
  • Orthofix
  • MediWound
  • Aurealis Therapeutics
  • Kericis
  • MiMedx
  • Fidia
  • Convatec
  • AlloSource
  • Cytori
  • Ethicon
  • Integra LifeSciences
  • Medline Industries
  • Marine Polymer Technologies
  • Molnlycke
  • Stryker
  • BD
  • Zimmer Biomet
  • RedDress
REPORT HIGHLIGHTS

PRODUCT SEGMENTATION & FORECAST
  • By Product
  • Biological Skin Substitutes
  • Growth Factors
  • By Wound Type
  • Chronic Wounds
  • Acute Wounds
  • End-user
  • Specialty Wound Care Clinics
  • Hospitals
  • Long-Term Care Centers
MARKET STRUCTURE
  • Market Dynamics
  • Competitive Landscape of Wound Biologics Market
  • Key Vendors
  • Other Prominent Vendors
APPENDIX
  • Research Methodology
  • Abbreviations
  • About Arizton

Table of Contents

76 Pages
CHAPTER – 1: Wound Biologics Market Overview
Executive Summary
Key Findings
CHAPTER – 2: Wound Biologics Market
Europe: Projected Revenue of Wound Biologics Market (2022-2028; $Millions)
CHAPTER – 3: Wound Biologics Market Segmentation Data
Europe: Projected Revenue by Product (2022-2028; $Millions)
o Biological Skin Substitutes
o Growth Factors
Europe: Projected Revenue by Wound Type (2022-2028; $Millions)
o Chronic Wounds
o Acute Wounds
Europe: Projected Revenue by End-user (2022-2028; $Millions)
o Specialty Wound Care Clinics
o Hospitals
o Long-Term Care Centers
CHAPTER – 4: Key Countries Overview
o Projected Revenue of Wound Biologics Market in UK
o Projected Revenue of Wound Biologics Market in Germany
o Projected Revenue of Wound Biologics Market in France
o Projected Revenue of Wound Biologics Market in Italy
o Projected Revenue of Wound biologics Market in Spain
CHAPTER – 5: Wound Biologics Market Prospects & Opportunities
Wound Biologics - Market Opportunities & Trends
Wound Biologics - Market Drivers
Wound Biologics - Market Constraints
CHAPTER – 6: Wound Biologics Industry Overview
Wound Biologics Market - Competitive Landscape
Wound Biologics Market – Key Vendor Profiles
Wound Biologics Market - Other Prominent Vendors
Wound Biologics Market - Key Strategic Recommendations
CHAPTER – 7: Appendix
Research Methodology
Abbreviations
About Arizton

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us